Vnitr Lek 2021, 67(6):346-350 | DOI: 10.36290/vnl.2021.091

High-rank technology in the medicine - the impact of continuous glucose monitoring system alarm settings values on glycemic control in type 1 diabetes patients: a systematic review

Jana Urbanová1, Juraj Michalec2, Jan Brož2
1 Interní klinika FNKV a 3. LF UK, Praha
2 Interní klinika FN Motol a 2. LF UK, Praha

Alarms in continuous glucose monitoring systems (CGM) represent a very important feature enabling to patients with diabetes who use these systems to keep their blood glucose level in the target range and to avoid excursion to hypoglycemia or hyperglycemia. The possibility to warn the patient that the target range has been crossed means one of the main advantages of CGM over the selfmonitoring of blood glucose with personal glucometers, but also (so far) flash glucose monitoring systems. However, there is surprisingly few studies concerning specifically the relationship between the alarms settings and glucose control. Therefore, there are currently no recommendations nor guidelines for optimal settings of alarms in CGM. Limited number of studies suggest that the setting of the hypoglycemia alarm to a level higher than 4 mmol/L is associated with lower frequency and shorter duration of hypoglycemia, and may be temporarily increased to 6 mmol/L in patients with impaired hypoglycemia awareness.

Keywords: alarms, CGM, diabetes, hyperglycemia, hypoglycemia.

Published: October 13, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Urbanová J, Michalec J, Brož J. High-rank technology in the medicine - the impact of continuous glucose monitoring system alarm settings values on glycemic control in type 1 diabetes patients: a systematic review. Vnitr Lek. 2021;67(6):346-350. doi: 10.36290/vnl.2021.091.
Download citation

References

  1. Battelino T, Danne T, Bergenstal RM et al. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care. 2019; 42(8): 1593-1603. Go to original source... Go to PubMed...
  2. Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabetic Medicine. 2021; 18. Go to original source... Go to PubMed...
  3. Lin YK, Groat D, Chan O, Hung M, Sharma A, Varner MW, Gouripeddi R, Facelli JC, Fisher SJ. Alarm Settings of Continuous Glucose Monitoring Systems and Associations to Glucose Outcomes in Type 1 Diabetes. J Endocr Soc. 2019; 4(1): bvz005. Go to original source... Go to PubMed...
  4. Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW. Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care. 2011; 34(1): 50-52. Go to original source... Go to PubMed...
  5. Puhr S, Derdzinski M, Welsh JB et al. Real-World Hypoglycemia Avoidance with a Continuous Glucose Monitoring System's Predictive Low Glucose Alert. Diabetes Technol Ther. 2019; 21(4): 155-158. Go to original source... Go to PubMed...
  6. Puhr S, Derdzinski M, Parker AS et al. Real-World Hypoglycemia Avoidance With a Predictive Low Glucose Alert Does Not Depend on Frequent Screen Views. J Diabetes Sci Technol. 2020; 14(1): 83-86. Go to original source... Go to PubMed...
  7. Shivers JP, Mackowiak L, Anhalt H, Zisser H. "Turn it off!": diabetes device alarm fatigue considerations for the present and the future. J Diabetes Sci Technol. 2013; 7(3): 789-94. Go to original source... Go to PubMed...
  8. Palerm CC, Bequette BW. Hypoglycemia detection and prediction using continuous glucose monitoring-a study on hypoglycemic clamp data. J Diabetes Sci Technol. 2007; 1(5): 624-9. Go to original source... Go to PubMed...
  9. Little SA, Leelarathna L, Walkinshaw E et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care. 2014;37(8): 2114-22. Go to original source... Go to PubMed...
  10. LBL016357+Rev+001+G6+Using+Your+G6+OUS+CZ+mmolL_Web+(1).pdf
  11. MM780G+IFU+CZ+-+M003192C021DOC_A_FINAL_PRINT (1).pdf
  12. IFU_MiniMed_640G.pdf
  13. S7_návod+k+použití_03.2020.pdf




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.